HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients.

Abstract
A single dose therapy of 500 mg ciprofloxacin was sufficient to cure 15 of 18 chancroid patients within six days and the remaining three within 7, 11 and 20 days respectively. The drug was well tolerated, and no serious side effects were observed. The MICs of ciprofloxacin for the isolated Haemophilus ducreyi strains ranged from 0.0015 to 0.02 mg/l (mean 0.01 mg/l). It may therefore be concluded from our study that the oral administration of ciprofloxacin to chancroid patients with or without buboes is highly effective and free from side effects.
AuthorsA Traisupa, C Wongba, P Tesavibul
JournalInfection (Infection) Vol. 16 Suppl 1 Pg. S44-5 ( 1988) ISSN: 0300-8126 [Print] Germany
PMID3286513 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Ciprofloxacin
Topics
  • Administration, Oral
  • Adult
  • Chancroid (drug therapy)
  • Ciprofloxacin (administration & dosage, therapeutic use)
  • Clinical Trials as Topic
  • Humans
  • Male
  • Thailand

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: